WeVote

Bill

Bill

HB 1463

Pseudoephedrine; require manufacturers to pay fees to National Association of Drug Diversion Investigators to support NPLE.

2025 Regular Session

Mississippi requires pseudoephedrine manufacturers to pay fees supporting a law enforcement database that tracks precursor chemical sales to prevent methamphetamine production.

Approved by Governor
0
WeVote Research Nonpartisan
Bill Summary · HB 1463

Legislative bill overview

HB 1463 establishes a fee requirement for pseudoephedrine manufacturers, with proceeds directed to the National Association of Drug Diversion Investigators (NADDI) to support the National Precursor Logistical Exchange (NPLE). The NPLE is a database that tracks sales of over-the-counter products containing pseudoephedrine to combat methamphetamine production. This represents a shift in funding responsibility from traditional sources to manufacturers themselves.

Why is this important

Pseudoephedrine is a common cold and allergy medication that can be diverted for illegal methamphetamine synthesis. The NPLE helps law enforcement identify suspicious purchasing patterns before drugs reach clandestine labs. By requiring manufacturers to fund this monitoring system, Mississippi is attempting to distribute anti-drug enforcement costs to the industries whose products are being misused, rather than relying solely on public funding.

Potential points of contention

  • Cost pass-through concerns: Manufacturers may pass fee costs to consumers, potentially raising prices for legitimate users of pseudoephedrine-containing medications
  • Industry fairness questions: Only pseudoephedrine manufacturers pay, while other potentially diverted chemicals or products may not face similar requirements, creating an uneven regulatory burden
  • NPLE effectiveness debate: Stakeholders disagree on whether the NPLE's effectiveness justifies requiring manufacturers to fund it, or if this represents overreach in assigning private sector responsibility for drug enforcement

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.